News & Events
ERX Pharmaceuticals Announces Appointment of Chief Medical Officer Barbara Troupin, MD, MBA and Chief Financial Offer Jonathan Lieber, MBA
ERX Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the discovery and clinical development of innovative treatments for obesity and related diseases, announced the expansion of its executive leadership team with the appointments of Barbara Troupin, MD, MBA as Chief Medical Officer and Jonathan Lieber, MBA as Chief Financial Officer.